Tractable Quinolone Hydrazides Exhibiting Sub‐Micromolar and Broad Spectrum Antitrypanosomal Activities
Open Access
- 23 February 2024
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 19 (9) , e202300667
Abstract
Nagana and Human African Trypanosomiasis (HAT), caused by (sub)species of Trypanosoma, are diseases that impede human and animal health, and economic growth in Africa. The few drugs available have drawbacks including suboptimal efficacy, adverse effects, drug resistance, and difficult routes of administration. New drugs are needed. A series of 20 novel quinolone compounds with affordable synthetic routes was made and evaluated in vitro against Trypanosoma brucei and HEK293 cells. Of the 20 compounds, 12 had sub‐micromolar potencies against the parasite (EC50 values=0.051–0.57 μM), and most were non‐toxic to HEK293 cells (CC50 values>5 μM). Two of the most potent compounds presented sub‐micromolar activities against other trypanosome (sub)species (T. cruzi and T. b. rhodesiense). Although aqueous solubility is poor, both compounds possess good logD values (2–3), and either robust or poor microsomal stability profiles. These varying attributes will be addressed in future reports.Keywords
This publication has 55 references indexed in Scilit:
- Bridging solubility between drug discovery and developmentDrug Discovery Today, 2012
- Antitrypanosomal Activity of Fexinidazole, a New Oral Nitroimidazole Drug Candidate for Treatment of Sleeping SicknessAntimicrobial Agents and Chemotherapy, 2011
- Identification of Stage Biomarkers for Human African TrypanosomiasisThe American Journal of Tropical Medicine and Hygiene, 2010
- The development of drugs for treatment of sleeping sickness: a historical reviewParasites & Vectors, 2010
- The history of African trypanosomiasisParasites & Vectors, 2008
- Experimental Design on Single-Time-Point High-Throughput Microsomal Stability AssayJournal of Pharmaceutical Sciences, 2004
- The Trypanocide Diminazene Aceturate Is Accumulated Predominantly through the TbAT1 Purine Transporter: Additional Insights on Diamidine Resistance in African TrypanosomesAntimicrobial Agents and Chemotherapy, 2004
- Screening of acyl hydrazide proteinase inhibitors for antiparasitic activity against Trypanosoma bruceiInternational Journal of Antimicrobial Agents, 2002
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997
- Drug used in the treatment of sleeping sickness (human African trypanosomiasis: HAT)International Journal of Antimicrobial Agents, 1994